fenofibric acid has been researched along with Leukostasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Du, Y; Ma, JX; Matlock, G; Qiu, F; Wang, X; Zhou, K | 1 |
| Chen, Q; Deng, G; Du, Y; Ma, JX; Ma, X; Matlock, G; Meng, T; Qiu, F; Shao, Y; Wang, X; Wu, W; Xu, Q; Zhou, K | 1 |
2 other study(ies) available for fenofibric acid and Leukostasis
| Article | Year |
|---|---|
Therapeutic Effects of PPARĪ± Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
Topics: Animals; Blotting, Western; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Fenofibrate; Fluorescein Angiography; Hypolipidemic Agents; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Leukostasis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR alpha; Rats; Rats, Inbred BN; Receptors, LDL; Tomography, Optical Coherence; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2017 |
Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Topics: Animals; Capillary Permeability; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drug Delivery Systems; Drug Liberation; Fenofibrate; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Leukostasis; Mice; Mice, Knockout; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred BN; Retina; Streptozocin; Tissue Distribution; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2019 |